ReviewAdvances in experimental medicine and biology2025
Brain-Resident Immune Cells in Neurodevelopmental Disorders.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Retinal pigment epithelium pathology in age-related macular degeneration: mitigation with melatonin.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain-resident immune cells are involved in the protection against microbes invading the brain. In addition, their essential role in regulating physiological processes, including neurogenesis and neuronal migration, has been documented. In this chapter, we will provide a general introduction to immune cell types that reside and infiltrate the brain. Furthermore, the impact of brain-resident immune cells on brain physiology will be discussed. The phenotype of immune cells is known to be impaired in neurodevelopmental disorders. Thus, we will describe how the accumulation of dysfunctional immune cell types contributes to the pathogenesis of this group of diseases, with a particular emphasis on the connection between immune dysfunction, inflammation, and oxidative stress. Finally, possible interventions to counteract neurodevelopmental disorders by targeting oxidative stress and inflammation will be summarized.
Indexed as
Identifiers
40442390What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.